3.20

0.62% -0.02

Silo Pharma Inc (SILO)

Overview News Price History Financials Discussions Forecast Stock Split

Silo Pharma Inc stock is traded at $3.20, with a volume of 27,971. It is down -0.62% in the last 24 hours and down -37.62% over the past month. SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.

Previous Close:

$3.22

Open:

$3.25

24h Volume:

27,971

Relative Volume:

0.18

Market Cap:

$4.01M

Revenue:

$72,100

Net Income/Loss:

$-4.84M

P/E Ratio:

-0.4292

EPS:

-7.4566

Net Cash Flow:

$-3.84M

1W Performance:

-14.32%

1M Performance:

-37.62%

6M Performance:

-26.69%

1Y Performance:

-69.18%

1-Day Range:

$3.09

$3.34

1-Week Range:

$2.75

$3.90

52-Week Range:

$2.75

$15.15

Silo Pharma Inc Stock (SILO) Company Profile

Name

Silo Pharma Inc

Sector

Healthcare (1080)

Industry

Biotechnology (604)

Phone

(718) 400-9031

Address

677 N. WASHINGTON BLVD, SARASOTA

Employee

Twitter

Next Earnings Date

2026-08-12

Latest SEC Filings

SILO's Discussions on Twitter

Compare SILO vs MOBBW, PSNYW, GOODO, SHMD, DWLD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SILO SILO PHARMA INC	1.71	17.96M	0	0	0	0.00
MOBBW Mobilicom Limited Warrants	1.86	2.83B	0	0	0	0.00
PSNYW Polestar Automotive Holding Uk	2.89	388.34M	2.07B	-1.42B	-1.37B	-0.6765
GOODO Gladstone Commercial Corporation	20.88	372.90M	0	0	0	0.00
SHMD Schmid Group N V	5.45	348.74M	52.15M	-21.46M	0	-0.4675
DWLD Davis Select Worldwide ETF	48.03	0	0	0	0	0.00

Silo Pharma Inc Stock (SILO) Latest News

Aug 13, 2026

Silo Pharma (SILO) trims cash burn, mitigates going-concern risk in Q2 2026 - Stock Titan

Aug 13, 2026

Silo Pharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 13, 2026

Silo Pharma (SILO) investor group discloses 9.99% warrant-based ownership cap - Stock Titan

Aug 13, 2026

Aug 10, 2026

Silo Pharma receives European patent for SPC-15 PTSD treatment By Investing.com - Investing.com South Africa

Aug 10, 2026

Silo Pharma Announces European Patent Grant for SPC-15 PTSD Prevention Therapy - quiverquant.com

Aug 10, 2026

A nasal PTSD treatment is patented for use before extreme stress - Stock Titan

Aug 10, 2026

Aug 07, 2026

Silo Pharma, Inc. SEC Filing (Aug 7, 2026) - Stock Titan

Aug 07, 2026

Aug 06, 2026

Silo Pharma Subsidiary QwikAgents Collaborates with Amazon Web Services Premier Tier Partner Caylent to Advance Enterprise AI Platform - marketscreener.com

Aug 06, 2026

QwikAgents' planned AWS platform is expected to improve security and scale - Stock Titan

Aug 06, 2026